Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America

Journal of Infectious Diseases

Volumn 186, Issue 7, 2002, Pages 999-1006

  Cortese, Joseph F ^a   Caraballo, Alejandro ^b   Contreras, Carmen E ^c   Plowe, Christopher V ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b Ministry of Health   (Venezuela)

^c entral University   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FANSIDAR; FOLIC ACID ANTAGONIST;

ALLELE; ARTICLE; GENE LOCUS; GENE MUTATION; HAPLOTYPE; MALARIA CONTROL; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SOUTH AMERICA;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; ANTIMALARIALS; CHLOROQUINE; CLONING, MOLECULAR; DRUG RESISTANCE, MULTIPLE; FOLIC ACID ANTAGONISTS; HAPLOTYPES; HUMANS; MALARIA, FALCIPARUM; MICROSATELLITE REPEATS; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; MUTATION; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SOUTH AMERICA; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE; THYMIDYLATE SYNTHASE;

EID: 0036786291     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/342946     Document Type: Article

References (36)

1. Butler WP, Roberts DR. Malaria in the Americas: a model of reemergence. Mil Med 2000;165:897-902.
2. Pan American Health Organization. Situation of malaria programs in the Americas. Epidemiol Bull 2001;22:10-4.
3. Schmidt LH, Coatney GR. Review of investigations in malaria chemotherapy (USA) 1946 to 1954. Am J Trop Med Hyg 1955;2:208-15.
4. Gabaldon A, Berti AL. The first large area in the tropical zone to report malaria eradication: north-central Venezuela. Am J Trop Med Hyg 1954;3:793-807.
5. Pinotti M. A new method of malaria prophylaxis: the addition of an antimalarial drug to cooking salt used in daily preparation of food. Rev Brasil Malariol 1954;6:5-12.
6. Gabaldon A, Guerrero L. An attempt to eradicate malaria by the weekly administration of pyrimethamine in areas of out-of-doors transmission in Venezuela. Am J Trop Med Hyg 1959;8:433-9.
7. Maberti S. Desarrollo de resistencia a la pirimetamina. Arch Ven Med Trop Parasitol Med 1960;3:329-59.
8. Mooore DV, Lanier JE. Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine. Am J Trop Med Hyg 1961;10:5-9.
9. Box ED, Box QT, Young MD. Chloroquine resistance of Plasmodium falciparum from Porto Velho, Brazil. Am J Trop Med Hyg 1963;12:300-4.
10. Espinal CA, Cortes GT, Guerra P, Arias AE. Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia. Am J Trop Med Hyg 1985;34:675-80.
11. Wyler DJ. Malaria: resurgence, resistance, and research. (First of two parts.) N Engl J Med 1983;308:875-8.
12. Shanks GD, Karwacki JJ, Singharaj P. Malaria prophylaxis during military operations in Thailand. Mil Med 1989;154:500-2.
13. Chin W, Contacos PG, Coatney GR, King HK. The evaluation of sulfonamides, alone or in combination with pyrimethamine, in the treatment of multi-resistant falciparum malaria. Am J Trop Med Hyg 1966;15:823-9.
14. Walker AJ, Lopez-Antunano FJ. Response to drugs of South American strains of Plasmodium falciparum. Trans R Soc Trop Med Hyg 1968;62:654-67.
15. Godoy GA, Volcan GS, Guevara R, Medrano C, Castro J, Texeira A. Venezuelan strains of Plasmodium falciparum resistant to sulfa and pyrimethamine as demonstrated by in vitro test. Rev Latinoam Microbiol 1977;19:229-31.
16. Ferraroni JJ, Hayes J. Drug-resistant falciparum malaria among the Mayongong Indians in the Brazilian Amazon. Am J Trop Med Hyg 1979;28:909-11.
17. Chemotherapy of malaria and resistance to antimalarials: report of a WHO scientific group. World Health Organ Tech Rep Ser 1973;529:1-121.
18. Alecrim WD, Dourado H, Alecrim M, Passos LF, Wanssa E, Albuquerque B. In vivo resistance of Plasmodium falciparum to a combination of sulfadoxine plus pyrimethamine at RIII level in Amazonas, Brazil [in Portuguese]. Rev Inst Med Trop Sao Paulo 1982;24(Suppl 6):52-3.
19. Roper MH, Torres RS, Goicochea CG, et al. The epidemiology of malaria in an epidemic area of the Peruvian Amazon. Am J Trop Med Hyg 2000;62:247-56.
20. Plowe CV. Folate antagonists and mechanisms of resistance. In: Rosenthal PJ, ed. Antimalarial chemotherapy. Totowa, NJ: Humana Press, 2001:173-90.
21. Plowe CV, Cortese JF, Djimde A, et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 1997;176:1590-6.
22. Urdaneta L, Lal A, Barnabe C, et al. Evidence for clonal propagation in natural isolates of Plasmodium falciparum from Venezuela. Proc Natl Acad Sci USA 2001;98:6725-9.
23. Mendez F, Munoz A, Carrasquilla G, et al. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Am J Epidemiol 2002;156:230-8.
24. Contreras CE, Cortese JF, Caraballo A, Plowe CV. Genetics of drug-resistant falciparum malaria in the Venezuelan state of Bolivar. Am J Trop Med Hyg (in press).
25. Vasconcelos KF, Plowe CV, Fontes CJ, et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon region of Brazil. Mem Inst Oswaldo Cruz 2000;95:721-8.
26. Kublin JG, Witzig RS, Shankar AH, et al. Molecular assays for surveillance of antifolate-resistant malaria. Lancet 1998;351:1629-30.
27. Su X, Wellems TE. Toward a high resolution Plasmodium falciparum linkage map: polymorphic markers from hundreds of simple sequence repeats. Genomics 1996;33:430-44.
28. Burkot TR, Williams JL, Schneider I. Infectivity to mosquitoes of Plasmodium falciparum clones grown in vitro from the same isolate. Trans R Soc Trop Med Hyg 1984;78:339-41.
29. Fidock DA, Nomura T, Talley AK, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 2000;6:861-71.
30. Wellems TE, Plowe CV. Chloroquine-resistant malaria. J Infect Dis 2001;184:770-6.
31. Mehlotra RK, Fujioka H, Roepe PD, et al. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc Natl Acad Sci USA 2001;98:12689-94.
32. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000;403:906-9.
33. Kerr PJ, Ranford-Cartwright LC, Walliker D. Proof of intragenic recombination in Plasmodium falciparum. Mol Biochem Parasitol 1994;66:241-8.
34. Murray BE, Alvarado T, Kim KH, et al. Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries. J Infect Dis 1985;152:1107-13.
35. Cortese JF, Plowe CV. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast. Mol Biochem Parasitol 1998;94:205-14.
36. Paul RE, Packer MJ, Walmsley M, et al. Mating patterns in malaria parasite populations of Papua New Guinea. Science 1995;269:1709-11.